Jovana Dobreva

Mrs. Jovana Dobreva

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2023 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
Dimitar TrajanovDimitar Trajanov
Dimitar Trajanov
VTVangel Trajkovski
Vangel Trajkovski
MDMakedonka Dimitrieva
Makedonka Dimitrieva
JDJovana Dobreva
Jovana Dobreva
Milos JovanovikMilos Jovanovik
Milos Jovanovik
MRMarko Robnik-Šikonja
Marko Robnik-Šikonja
Natural language processing (NLP) is an area of artificial intelligence that applies information technologies to process the human language, understand it to a certain degree, and use it in various applications. This area has rapidly developed in the last few years and now employs modern variants of deep neural networks to extract relevant patterns from large text corpora. The main objective of this work is to survey the recent use of NLP in the field of pharmacology. As our work shows, NLP is a highly relevant information extraction and processing approach for pharmacology. It has been used extensively, from intelligent searches through thousands of medical documents to finding traces of adversarial drug interactions in social media. We split our coverage into five categories to survey modern NLP methodology, commonly addressed tasks, relevant textual data, knowledge bases, and useful programming libraries. We split each of the five categories into appropriate subcategories, describe their main properties and ideas, and summarize them in a tabular form. The resulting survey presents a comprehensive overview of the area, useful to practitioners and interested observers. Significance Statement The main objective of this work is to survey the recent use of NLP in the field of pharmacology, in order to provide a comprehensive overview of the current state in the area after the rapid developments which occurred in the last few years. We believe the resulting survey to be useful to practitioners and interested observers in the domain.

10 November 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MSMonika Simjanoska
Monika Simjanoska
DSDragan Shahpaski
Dragan Shahpaski
JDJovana Dobreva
Jovana Dobreva
DBDjansel Bukovec
Djansel Bukovec
BGBlagojche Gjorgjioski
Blagojche Gjorgjioski
MATJAZ GAMSMATJAZ GAMS
MATJAZ GAMS
The integration of artificial intelligence (AI) into clinical workflows is advancing even before full compliance with the European Union Cross-Border eHealth Network (MyHealth@EU) framework is achieved. While AI-based clinical decision support systems are automatically classified as high risk under the European Union’s AI Act, cross-border health data exchange must also satisfy MyHealth@EU interoperability requirements. This creates a dual-compliance challenge: vertical safety and ethics controls mandated by the AI Act and horizontal semantic transport requirements enforced through Open National Contact Point (OpenNCP) gateways, many of which are still maturing toward production readiness. This paper provides a practical, phase-oriented tutorial that enables developers and providers to embed AI Act safeguards before approaching MyHealth@EU interoperability tests. The goal is to show how AI-specific metadata can be included in the Health Level Seven International Clinical Document Architecture and Fast Healthcare Interoperability Resources messages without disrupting standard structures, ensuring both compliance and trustworthiness in AI-assisted clinical decisions. We systematically analyzed Regulation (EU) 2024/1689 (AI Act) and the OpenNCP technical specifications, extracting a harmonized set of overlapping obligations. The AI Act provisions on transparency, provenance, and robustness are mapped directly onto MyHealth@EU workflows, identifying the points where outgoing messages must record AI involvement, log provenance, and trigger validation. To operationalize this mapping, we propose a minimal extension set, covering AI contribution status, rationale, risk classification, and Annex IV documentation links, together with a phase-based compliance checklist that aligns AI Act controls with MyHealth@EU conformance steps. A simulated International Patient Summary transmission demonstrates how Clinical Document Architecture/Fast Healthcare Interoperability Resources extensions can annotate AI involvement, how OpenNCP processes such enriched payloads, and how clinicians in another member state view the result with backward compatibility preserved. We expand on security considerations (eg, Open Worldwide Application Security Project generative AI risks such as prompt injection and adversarial inputs), continuous postmarket risk assessment, monitoring, and alignment with MyHealth@EU’s incident aggregation system. Limitations reflect the immaturity of current infrastructures and regulations, with real-world validation pending the rollout of key dependencies. AI-enabled clinical software succeeds only when AI Act safeguards and MyHealth@EU interoperability rules are engineered together from day 0 . This tutorial provides developers with a forward-looking blueprint that reduces duplication of effort, streamlines conformance testing, and embeds compliance early. While the concept is still in its early phases of practice, it represents a necessary and worthwhile direction for ensuring that future AI-enabled clinical systems can meet both European Union regulatory requirements from day 1. risks such as prompt injection and adversarial inputs), continuous postmarket risk assessment, monitoring, and alignment with MyHealth@EU’s incident aggregation system. Limitations reflect the immaturity of current infrastructures and regulations, with real-world validation pending the rollout of key dependencies.

19 May 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JDJovana Dobreva
Jovana Dobreva
MSMonika Simjanoska
Monika Simjanoska
KMKostadin Mishev
Kostadin Mishev
Dimitar TrajanovDimitar Trajanov
Dimitar Trajanov
Igor MishkovskiIgor Mishkovski
Igor Mishkovski
This review paper synthesizes the application of knowledge graphs (KGs) in Alzheimer’s disease (AD) research, based on two basic questions, as follows: what types of input data are available to construct these knowledge graphs, and what purpose the knowledge graph is intended to fulfill. We synthesize results from existing works to illustrate how diverse knowledge graph structures behave in different data availability settings with distinct application targets in AD research. By comparative analysis, we define the best methodology practices by data type (literature, structured databases, neuroimaging, and clinical records) and application of interest (drug repurposing, disease classification, mechanism discovery, and clinical decision support). From this analysis, we recommend AD-KG 2.0, which is a new framework that coalesces best practices into a unifying architecture with well-defined decision pathways for implementation. Our key contributions are as follows: (1) a dynamic adaptation mechanism that adapts methodological elements automatically according to both data availability and application objectives, (2) a specialized semantic alignment layer that harmonizes terminologies across biological scales, and (3) a multi-constraint optimization approach for knowledge graph building. The framework accommodates a variety of applications, including drug repurposing, patient stratification for precision medicine, disease progression modeling, and clinical decision support. Our system, with a decision tree structured and pipeline layered architecture, offers research precise directions on how to use knowledge graphs in AD research by aligning methodological choice decisions with respective data availability and application goals. We provide precise component designs and adaptation processes that deliver optimal performance across varying research and clinical settings. We conclude by addressing implementation challenges and future directions for translating knowledge graph technologies from research tool to clinical use, with a specific focus on interpretability, workflow integration, and regulatory matters.

10 October 2025 in Data in Brief
Verified
Journal Article
Open access
JDJovana Dobreva
Jovana Dobreva
IKIvana Karasmanakis
Ivana Karasmanakis
FIFilip Ivanisevic
Filip Ivanisevic
THTadej Horvat
Tadej Horvat
DKDimitar Kitanovski
Dimitar Kitanovski
MSMonika Simjanoska
Monika Simjanoska
The paper introduces RAGCare-QA, an extensive dataset of 420 theoretical medical knowledge questions for assessing Retrieval-Augmented Generation (RAG) pipelines in medical education and evaluation settings. The dataset includes one-choice-only questions from six medical specialties (Cardiology, Endocrinology, Gastroenterology, Family Medicine, Oncology, and Neurology) with three levels of complexity (Basic, Intermediate, and Advanced). Each question is accompanied by the best fit of RAG implementation complexity level, such as Basic RAG (315 questions, 75.0 %), Multi-vector RAG (82 questions, 19.5 %), and Graph-enhanced RAG (23 questions, 5.5 %). The questions emphasize theoretical medical knowledge on fundamental concepts, pathophysiology, diagnostic criteria, and treatment principles important in medical education. The dataset is a useful tool for the assessment of RAG- based medical education systems, allowing researchers to fine-tune retrieval methods for various categories of theoretical medical knowledge questions.

12 April 2022
Verified
Book Chapter
Closed access
PDF file
JDJovana Dobreva
Jovana Dobreva
Milos JovanovikMilos Jovanovik
Milos Jovanovik
Dimitar TrajanovDimitar Trajanov
Dimitar Trajanov

1 January 2022
Verified
Book Chapter
Closed access
PDF file
JDJovana Dobreva
Jovana Dobreva
TPTashko Pavlov
Tashko Pavlov
KMKostadin Mishev
Kostadin Mishev
MSMonika Simjanoska
Monika Simjanoska
STStojancho Tudzarski
Stojancho Tudzarski
LKLjupcho Kocarev
Ljupcho Kocarev